Ohio Clinical Laboratory Requirements

Ohio does not have a general independent clinical laboratory licensing requirement established by the evidence reviewed for this guide. The Ohio Department of Health (ODH) administers the federal Clinical Laboratory Improvement Amendments (CLIA) program and monitors clinical laboratories for compliance with applicable federal and state requirements.

Most independent clinical laboratories performing routine human-specimen testing should begin with the appropriate federal CLIA certification. However, certain specialized activities require additional Ohio approval.

General Ohio laboratory licensure: Needs state confirmation — no general independent clinical laboratory license was established by the evidence reviewed for this guide; confirm facility-specific and specialty-specific requirements with ODH before opening or expanding a laboratory.

Scope of this guide

This guide addresses a typical independent commercial clinical laboratory testing human specimens; it is not a legal opinion or final facility-opening checklist. Facility licensure, personnel licensure, hospital/facility rules, out-of-state testing permits, payer enrollment, and specialty rules are separate questions — confirm each with the state authority. "Needs state confirmation" means no definitive conclusion was established; it does not mean the state has no additional requirements. Before relying on this guide, verify with the state: ownership/facility type, testing complexity and specialties, whether specimens are collected or tested in-state, whether tests are sent out of state, and whether personnel licenses are required.

State agency

Ohio Department of Health (ODH) — acts as Ohio's CLIA state agency (surveys, certification, and enforcement for federally certified labs). ODH's Laboratory Certification Program monitors more than 13,400 laboratories for compliance with federal CLIA requirements under 42 CFR Part 493 and applicable Ohio requirements.

  • ODH Laboratory Certification / CLIA Program — Ohio Department of Health, Bureau of Survey and Certification, CLIA Program, 246 N. High St., 1st Floor, Columbus, OH 43215; CLIA@odh.ohio.gov; (614) 644-1845.
  • Lead Licensure and Accreditation Program (clinical lead laboratory approval) — lead@odh.ohio.gov; (614) 466-1450; Ohio Department of Health, Lead Poisoning Prevention Program, 246 North High Street, Columbus, OH 43215. Questions on lead reporting may also go to the Surveillance Coordinator for the Childhood Lead Poisoning Prevention Program at (800) 532-3723.

Ohio clinical laboratory licensing and state approval

Clinical laboratory approval for blood-lead testing

Under Ohio Revised Code §3742.09 and Ohio Administrative Code 3701-82-02, a laboratory performing blood-lead analysis for purposes covered by Ohio Revised Code Chapter 3742 must obtain ODH clinical laboratory approval. The rule has one exemption: a laboratory operated by the federal government is exempt from approval as an environmental lead analytical laboratory or a clinical lead laboratory (OAC 3701-82-02(G)).

The approval is additional to CLIA certification and is not a substitute for federal certification.

Key requirements include:

  • A current CLIA certificate or Certificate of Waiver.
  • An ODH application for clinical lead laboratory approval, submitted through ODH's online application system (or the paper application, HEA 5808) with supporting documentation and the $300 fee. Renewals use the same process. Contact the Lead Licensure and Accreditation Program (lead@odh.ohio.gov, (614) 466-1450) to confirm the current application route before filing.
  • A $300 application fee, payable to the Treasurer, State of Ohio. An application is complete when ODH receives the completed application, required supporting documentation, and the $300 fee. An incomplete application must be completed within 90 days after ODH's request for additional information, or it may be considered abandoned; a subsequent application requires another nonrefundable fee.
  • Compliance with Ohio lead-testing recordkeeping and reporting requirements.
  • Annual approval renewal. Initial approval expires 12 months from issuance and annually thereafter (OAC 3701-82-02(I)); expiration is not subject to appeal. Plan for annual renewal, not a one-time filing.
  • Notification to ODH within 24 hours if CLIA certification is revoked, suspended, or limited (OAC 3701-82-02(F)(1)).
  • Notification within five business days each time CLIA certification or a Certificate of Waiver is renewed or modified (OAC 3701-82-02(F)(2)).
  • Submission of a copy of your proficiency testing results performed under the CLIA program to ODH within five business days of receiving them (OAC 3701-32-14(B)).
  • Proficiency testing for waived blood-lead testing. An applicant that analyzes blood for lead content under a CLIA Certificate of Waiver must successfully participate in a proficiency testing program that is also acceptable for CLIA nonwaived blood-lead analysis (OAC 3701-82-02(E)(5)) — a PT obligation CLIA does not impose on waived testing generally.

The approval requirement turns on the testing performed under Chapter 3742, not on facility class — the rule's only exemption is for a federally operated laboratory, so confirm with ODH whether it applies to your laboratory.

Out-of-state laboratories: laboratories located outside Ohio that perform blood-lead testing for purposes covered by Ohio Revised Code Chapter 3742 should confirm their approval obligations directly with ODH. Ohio's reporting rules also apply to specified testing performed on Ohio residents, regardless of where the laboratory is located. ODH has issued approvals to out-of-state laboratories testing Ohio specimens.

Additional heavy-metal reporting

Ohio also requires specified reporting for laboratory testing involving lead, cadmium, mercury, and arsenic in specimens from Ohio residents. Under OAC 3701-32-14(C), the reporting requirements extend to blood, urine, and other bodily substances, with specified information submitted electronically within seven days of obtaining results.

These reporting requirements should be distinguished from the separate clinical laboratory approval requirement for blood-lead testing. The approval trigger and the broader reporting obligation are different things: not every laboratory performing cadmium, mercury, or arsenic testing automatically requires the clinical lead laboratory approval.

Blood-lead reporting for children: OAC 3701-30-05 requires electronic reporting of specified blood-lead results for Ohio residents younger than 16 within seven calendar days. The reporting framework also addresses adults aged 16 and older through OAC 3701-32-14 — the approval and reporting framework is not exclusively a childhood screening requirement.

Reportable disease reporting

Ohio's general reportable-disease rule applies to every laboratory, not just lead laboratories. Under OAC 3701-3-04 (effective October 1, 2025), the person in charge of any laboratory that examines specimens of human origin for evidence of a disease designated as reportable must report all positive results in the manner set out in OAC 3701-3-05. The deadlines are short: Class A results must be reported immediately by telephone to the local health jurisdiction, and Class B results by the end of the next business day. The same chapter also has a separate HIV/AIDS test-reporting rule (OAC 3701-3-12). For an independent laboratory, this reporting obligation will matter far more often than the lead-approval requirement.

Other specialized approvals

Separate Ohio requirements apply to environmental lead analytical laboratories and qualifying plasmapheresis centers. These are distinct from general clinical laboratory licensure and should be evaluated according to the laboratory's actual activities and facility type.

  • Environmental lead analytical laboratories — OAC 3701-82-02 establishes a separate approval pathway for laboratories performing environmental lead analysis (air, dust, soil, paint, water) for purposes covered by Ohio's lead laws, requiring NLLAP accreditation and quarterly proficiency testing. Drinking-water lead samples go to Ohio EPA-certified laboratories under OAC Chapter 3745-89 and are exempt from this rule.
  • Plasmapheresis centers — under ORC Chapter 3725 (§3725.02, §3725.03), establishments collecting plasma generally require an ODH certificate of approval, with hospitals treated separately under the statute. ODH also conducts inspections and requires annual renewal.

Facility-type notes: independent lab vs. hospital-based lab vs. physician-office lab

Facility and operational requirements can differ by facility class outside CLIA — a CLIA certificate does not replace a separate facility license when one is applicable. Confirm your facility's requirements with ODH. The difference among classes for general testing is in which CLIA certificate fits the testing:

  • Independent clinical laboratories typically hold a Certificate of Compliance — subject to routine biennial federal surveys — or a Certificate of Accreditation, surveyed by their accrediting organization, with CMS/state surveys limited to validation and complaint surveys.
  • Hospital-based laboratories hold the same nonwaived certificates; labs operating at multiple hospital sites should confirm with the ODH CLIA office whether one certificate covers the sites under the multiple-site exceptions. Generally, each separate location/address requires its own CLIA number, subject to exceptions.
  • Physician-office laboratories most often hold a Certificate of Waiver (waived tests only) or a Certificate for Provider-Performed Microscopy (PPM); both are federal CLIA categories with no extra Ohio credential for general testing. The exception is a waived POL that performs blood-lead testing under Chapter 3742: it needs the ODH clinical laboratory approval and must enroll in a proficiency testing program acceptable for nonwaived blood-lead testing (OAC 3701-82-02(E)(5)) — PT that CLIA does not require for waived tests.

For blood-lead testing under Chapter 3742, the ODH clinical laboratory approval applies based on the testing performed, not on facility class — the rule's only exemption is for a federally operated laboratory (OAC 3701-82-02(G)); confirm with ODH whether it applies to your laboratory.

What federal CLIA requires

  • Choose the right certificate type (generally one CLIA number per location/address, subject to exceptions), based on test complexity:
    • Certificate of Waiver — waived tests only; follow the manufacturer's instructions and hold a current CLIA certificate. No CLIA personnel qualification requirements apply to waived testing (the exemption concerns CLIA personnel qualification standards for waived testing).
    • Certificate for Provider-Performed Microscopy (PPM) — microscopy procedures performed by a physician, midlevel practitioner, or dentist during the patient's visit.
    • Certificate of Compliance — nonwaived testing, subject to on-site federal/state survey verifying compliance with CLIA regulations.
    • Certificate of Accreditation — nonwaived testing under a CMS-approved accreditation organization (e.g., CAP, COLA, The Joint Commission, AABB, ASHI, A2LA) instead of direct federal inspection.
  • Apply on Form CMS-116, CLIA Application for Certification — use the CMS "Apply for a CLIA Certificate" page for the current form. CMS updated Form CMS-116 effective November 9, 2026; the revised application must be used for new CLIA applications and updates to existing certificate information, and collects additional information including multiple email addresses, owner information, and the CMS Certification Number for laboratories within CMS-certified facilities. File the application with the Ohio CLIA state agency office.
  • Fees and certificates are electronic. CMS sends the fee notification by email with your CLIA identification number; pay the fee online at pay.gov. Your CLIA certificate arrives by email after payment; paper checks are no longer accepted. The two-year CLIA certification fee cycle remains applicable — do not confuse this federal two-year cycle with Ohio's separate annual clinical lead laboratory approval.
  • Keep CMS-209 accurate — maintain an accurate internal roster of all personnel performing testing, including their CLIA roles, qualifications, credentials, and experience. Be prepared to complete Form CMS-209, the Laboratory Personnel Report (PDF) (September 2025 revision) during the survey process; the surveyor uses it to review personnel qualifications. CMS-209 is not a separate routine personnel filing with an independent renewal deadline.
  • Notify the state agency of changes — for laboratories holding a Certificate of Compliance, 42 CFR §493.51 establishes a 30-day notification requirement for specified changes, including ownership, laboratory name, location, director, and technical supervisor. Notification requirements differ by certificate type and the type of change; do not treat 30 days as a universal deadline for every CLIA laboratory change. See the CMS State Operations Manual, Chapter 6.
  • Enroll in proficiency testing for regulated analytes, run the required quality control, and maintain a controlled test menu that matches the specialties on your certificate. Laboratories applying for Compliance or Accreditation initially operate under a registration certificate until the survey or accreditation verification is complete.
  • Personnel qualifications are federal: director, technical supervisor/consultant, clinical consultant, general supervisor, and testing personnel must meet the CLIA standards for the lab's test complexity — see the personnel section below.

Personnel requirements

No general Ohio laboratory personnel license was established by the sources reviewed for this guide — federal CLIA personnel standards apply to every position. National certification (e.g., ASCP, AMT) is what employers and accreditation organizations expect, but it is not a state license.

CMS enforcement discretion (QSO-25-21-CLIA, June 23, 2025): CMS is exercising enforcement discretion in limited circumstances for certain personnel qualification requirements. For laboratory directors qualifying under 42 CFR §493.1405(b)(2), CMS allows either at least one year of experience directing or supervising nonwaived laboratory testing or 20 continuing education credit hours in laboratory director responsibilities. CMS also announced enforcement discretion concerning certain additional continuing education requirements under specified personnel qualification pathways. This is not a universal alternative for every laboratory director or every CLIA personnel position. A pending CMS proposed rule would codify much of this enforcement discretion — covering personnel qualifications, remote review of data and images, and proficiency testing — but it is not yet final. See CMS QSO-25-21-CLIA (PDF).

For federal CLIA personnel standards by role, see Zilgene's CLIA personnel requirements: who your lab must have on staff.

Forms and references

Inspection preparedness

Federal surveyors verify that the specialties, sites, and director on your CMS-116 match current operations, that your CMS-209 personnel roster is current, and that your test menu is controlled and matches the certificate. Have ready before the surveyors arrive: documentation of CLIA personnel qualifications and competency, records demonstrating compliance with applicable proficiency-testing requirements, current test menus and specialties, documentation of the applicable CLIA certificate and laboratory locations, proficiency testing records with documented review of failures and corrective actions, QC records, competency assessments for testing personnel, and records of reportable-disease reporting under OAC 3701-3-04/3701-3-05 — including Class A immediate reports and Class B next-business-day reports.

If you hold the clinical lead laboratory approval, treat it as a second inspection package: keep the ODH approval letter and number on file, your CLIA-program PT submissions documented (copies sent to ODH within five business days of receipt), your electronic-reporting compliance records, and a log showing you met the 24-hour and five-day CLIA-status notification obligations — plus documentation of Ohio-specific notifications, PT submissions, and reporting compliance. An expired or lapsed lead approval is a separate Ohio violation even if your CLIA certificate is current.

How Ohio differs from federal CLIA

Ohio has no general independent clinical laboratory license established by the evidence reviewed — CLIA is the baseline credential, for facilities and personnel alike; confirm facility-specific requirements with ODH before relying on this. The state overlays are distinct approval pathways, not a single overlay: the clinical laboratory approval for blood-lead testing (ORC § 3742.09; OAC 3701-82-02 — numbered, annual, $300 application fee, with its own PT-submission, notification, and electronic-reporting duties, available only to CLIA-certified labs, reaching out-of-state labs testing Ohio specimens too); the separate environmental lead analytical laboratory approval; and the plasmapheresis-center certificate of approval (ORC Chapter 3725). Heavy-metal reporting (lead, cadmium, mercury, arsenic) applies to specified testing on Ohio residents regardless of where the laboratory is located. And separate from the lead framework, Ohio's general reportable-disease rule (OAC 3701-3-04, effective October 1, 2025) requires every laboratory to report positive results for reportable diseases — Class A immediately, Class B by the end of the next business day.

How Zilgene can help

Zilgene guides laboratories through CLIA certification, personnel qualification, inspection readiness — and Ohio-specific approvals like the clinical lead laboratory approval — nationwide. Contact us for a free first consultation — every engagement is scoped and quoted upfront. See also the Zilgene FAQ for common CLIA and certification questions.

Official links

Last verified: November 2026